Stock Markets What analysts call better-than-expected economic data, encouraging corporate earnings from U.S. banks, and the signing of the “phase-one” trade agreement helped raise U.S. stocks to fresh record highs last week. A surge in housing starts bolstered by strong retail sales point to a resilient consumer that is supported by a continued strong labor […]
Category: Uncategorized
IoT Experts Tapping into the Trillion Dollar Market One Solution at a Time
Sensor and Logistics Experts Direct Communications Services Inc. (CSE:DCSI) are Helping Businesses Monitor Their Assets “Anytime, Anywhere” The Internet of Things (IoT) revolution is well under way, as investors prepare for a world where worldwide technology spending on IoT that could surpass a trillion dollars in 2022.[[1]] Between 2017 and 2022, the sector is expected […]
Weekly Market Review – January 11, 2020
Stock Markets Stock markets closed at near new all-time highs last week after the U.S. and Iran recoiled and avoided expected escalation in geopolitical tensions. Iran took retaliatory steps for the death of its general with missile strikes against U.S. military bases in Iraq. There were no casualties, whether on purpose or not, but President […]
Weekly Market Review – January 4, 2020
Stock Markets Following a sharp rally at year-end and a new record high on the first trading day of the year, U.S. stocks declined modestly on the week, which many expected. New concerns over tensions between the U.S. and Iran popped up on Friday after a U.S. airstrike in Iraq killed an Iranian general who […]
HeyBryan Finds The Uber Formula in the Home Improvement Space
Homeowners and home-improvement experts are enthusiastically adopting HeyBryan, an app that’s rapidly re-shaping the home maintenance industry. In less than a year, investors in HeyBryan Media Inc. (CSE: HEY) have watched as the app grew an impressive ninefold. As disruptors appear on virtually every front from ride sharing to crafting, one shining newcomer is moving […]
Weekly Market Review – December 28, 2019
Stock Markets In the final week of 2019, stocks rose yet again as several major indexes hit fresh record highs. Volatility remained under control and stocks continued upward as we moved to year-end. There are, at present, no major catalysts or economic issues to disrupt the market rally. The S&P 500 is on track to […]
Weekly Market Review – December 21, 2019
Stock Markets Heading into the Christmas-holiday shortened trading week, stocks are set to finish the year strong. The S&P 500 has now posted 31 all-time highs in 2019, driven by sizable gains in the technology sector, progress on Brexit, the U.S./China trade front, and continued strength in the U.S. jobs market. Despite an impeachment vote […]
Weekly Market Review – December 14, 2019
Stock Markets As expected, U.S. stocks rallied to fresh record highs after the three main issues that have created most of the uncertainty this year came to a positive close. The trade deal, Brexit and the Fed policy all moved to new positive levels. The U.S. and China reached a “phase one” trade deal which […]
Weekly Market Review – December 7, 2019
Stock Markets While it was trade-deals that were expected to drive the markets last week, the limelight moved quickly to economic fundamentals, which drove global stocks higher. It appears that international stocks outperformed domestic ones based on the fourth straight month of improvement in global manufacturing PMI, which is seen as a reflection of global […]
Protected: Under-the-Radar Diverse Machinery Company Feeds The Major Manufacturers with Lucrative Parts and Infrastructure
There is no excerpt because this is a protected post.
Protected: Investors Should Be Paying Attention to This… Analysts Say
There is no excerpt because this is a protected post.
New Drug from Under-the-Radar Biotech Company Successfully Tricking the Body’s Immune System into Fighting Cancer Cells
Why So Many Multi-Billion-Dollar Pharma Giants Are Teaming with Oncolytics Biotech Inc. (NASDAQ:ONCY) (TSX:ONC) EDITOR’S NOTE* This page was last update on February 9, 2020 with a new pipeline chart of Oncolytics Pelareorep Clinical Studies Amid the fierce war being waged against cancer by drug developers, there’s a biotech segment growing at lightning speed (+20% […]